196 related articles for article (PubMed ID: 37408176)
1. Tanshinone I suppresses hepatocellular carcinoma cells growth through targeting DNA double-strand break repair.
Qian Z; Feng N; Geng A
Cancer Biol Ther; 2023 Dec; 24(1):2229958. PubMed ID: 37408176
[TBL] [Abstract][Full Text] [Related]
2. Rational combination therapy for hepatocellular carcinoma with PARP1 and DNA-PK inhibitors.
Wang C; Tang H; Geng A; Dai B; Zhang H; Sun X; Chen Y; Qiao Z; Zhu H; Yang J; Chen J; He Q; Qin N; Xie J; Tan R; Wan X; Gao S; Jiang Y; Sun FL; Mao Z
Proc Natl Acad Sci U S A; 2020 Oct; 117(42):26356-26365. PubMed ID: 33020270
[TBL] [Abstract][Full Text] [Related]
3. TKT-PARP1 axis induces radioresistance by promoting DNA double-strand break repair in hepatocellular carcinoma.
Geng L; Zhu M; Luo D; Chen H; Li B; Lao Y; An H; Wu Y; Li Y; Xia A; Shi Y; Tong Z; Lu S; Xu D; Wang X; Zhang W; Sun B; Xu Z
Oncogene; 2024 Feb; 43(9):682-692. PubMed ID: 38216672
[TBL] [Abstract][Full Text] [Related]
4. XLF-mediated NHEJ activity in hepatocellular carcinoma therapy resistance.
Yang S; Wang XQ
BMC Cancer; 2017 May; 17(1):344. PubMed ID: 28526069
[TBL] [Abstract][Full Text] [Related]
5. Analysis of chromatid-break-repair detects a homologous recombination to non-homologous end-joining switch with increasing load of DNA double-strand breaks.
Murmann-Konda T; Soni A; Stuschke M; Iliakis G
Mutat Res Genet Toxicol Environ Mutagen; 2021 Jul; 867():503372. PubMed ID: 34266628
[TBL] [Abstract][Full Text] [Related]
6. Roles for 53BP1 in the repair of radiation-induced DNA double strand breaks.
Shibata A; Jeggo PA
DNA Repair (Amst); 2020 Sep; 93():102915. PubMed ID: 33087281
[TBL] [Abstract][Full Text] [Related]
7. BRD4 inhibition induces synthetic lethality in ARID2-deficient hepatocellular carcinoma by increasing DNA damage.
He DD; Shang XY; Wang N; Wang GX; He KY; Wang L; Han ZG
Oncogene; 2022 Mar; 41(10):1397-1409. PubMed ID: 35017665
[TBL] [Abstract][Full Text] [Related]
8. Harmine suppresses homologous recombination repair and inhibits proliferation of hepatoma cells.
Zhang L; Zhang F; Zhang W; Chen L; Gao N; Men Y; Xu X; Jiang Y
Cancer Biol Ther; 2015; 16(11):1585-92. PubMed ID: 26382920
[TBL] [Abstract][Full Text] [Related]
9. Analysis of DNA Damage Responses After Boric Acid-mediated Boron Neutron Capture Therapy in Hepatocellular Carcinoma.
Chen KH; Lai ZY; Li DY; Lin YC; Chou FI; Chuang YJ
Anticancer Res; 2019 Dec; 39(12):6661-6671. PubMed ID: 31810931
[TBL] [Abstract][Full Text] [Related]
10. Metastasis Suppressor NME1 Modulates Choice of Double-Strand Break Repair Pathways in Melanoma Cells by Enhancing Alternative NHEJ while Inhibiting NHEJ and HR.
Puts G; Jarrett S; Leonard M; Matsangos N; Snyder D; Wang Y; Vincent R; Portney B; Abbotts R; McLaughlin L; Zalzman M; Rassool F; Kaetzel D
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32824412
[TBL] [Abstract][Full Text] [Related]
11. Age-associated deficient recruitment of 53BP1 in G1 cells directs DNA double-strand break repair to BRCA1/CtIP-mediated DNA-end resection.
Anglada T; Genescà A; Martín M
Aging (Albany NY); 2020 Dec; 12(24):24872-24893. PubMed ID: 33361520
[TBL] [Abstract][Full Text] [Related]
12. Understanding the DNA double-strand break repair and its therapeutic implications.
Ray U; Raghavan SC
DNA Repair (Amst); 2021 Oct; 106():103177. PubMed ID: 34325086
[TBL] [Abstract][Full Text] [Related]
13. ZMYM2 restricts 53BP1 at DNA double-strand breaks to favor BRCA1 loading and homologous recombination.
Lee D; Apelt K; Lee SO; Chan HR; Luijsterburg MS; Leung JWC; Miller KM
Nucleic Acids Res; 2022 Apr; 50(7):3922-3943. PubMed ID: 35253893
[TBL] [Abstract][Full Text] [Related]
14. Long Noncoding RNA NIHCOLE Promotes Ligation Efficiency of DNA Double-Strand Breaks in Hepatocellular Carcinoma.
Unfried JP; Marín-Baquero M; Rivera-Calzada Á; Razquin N; Martín-Cuevas EM; de Bragança S; Aicart-Ramos C; McCoy C; Prats-Mari L; Arribas-Bosacoma R; Lee L; Caruso S; Zucman-Rossi J; Sangro B; Williams G; Moreno-Herrero F; Llorca O; Lees-Miller SP; Fortes P
Cancer Res; 2021 Oct; 81(19):4910-4925. PubMed ID: 34321241
[TBL] [Abstract][Full Text] [Related]
15. DNA-PKcs: A promising therapeutic target in human hepatocellular carcinoma?
Pascale RM; Joseph C; Latte G; Evert M; Feo F; Calvisi DF
DNA Repair (Amst); 2016 Nov; 47():12-20. PubMed ID: 27789167
[TBL] [Abstract][Full Text] [Related]
16. The complexity of DNA double strand breaks is a critical factor enhancing end-resection.
Yajima H; Fujisawa H; Nakajima NI; Hirakawa H; Jeggo PA; Okayasu R; Fujimori A
DNA Repair (Amst); 2013 Nov; 12(11):936-46. PubMed ID: 24041488
[TBL] [Abstract][Full Text] [Related]
17. Ubiquitylation in DNA double-strand break repair.
Tang M; Li S; Chen J
DNA Repair (Amst); 2021 Jul; 103():103129. PubMed ID: 33990032
[TBL] [Abstract][Full Text] [Related]
18. Selenocystine induces oxidative-mediated DNA damage via impairing homologous recombination repair of DNA double-strand breaks in human hepatoma cells.
Wahyuni EA; Yii CY; Liang HL; Luo YH; Yang SH; Wu PY; Hsu WL; Nien CY; Chen SC
Chem Biol Interact; 2022 Sep; 365():110046. PubMed ID: 35863474
[TBL] [Abstract][Full Text] [Related]
19. The efficiency of homologous recombination and non-homologous end joining systems in repairing double-strand breaks during cell cycle progression.
Bee L; Fabris S; Cherubini R; Mognato M; Celotti L
PLoS One; 2013; 8(7):e69061. PubMed ID: 23874869
[TBL] [Abstract][Full Text] [Related]
20. One end to rule them all: Non-homologous end-joining and homologous recombination at DNA double-strand breaks.
Ensminger M; Löbrich M
Br J Radiol; 2020 Nov; 93(1115):20191054. PubMed ID: 32105514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
